📰 Ann Partridge News
Ann Partridge News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ann Partridge. Real-time updates on events, politics, business and more.
June 4, 2024
A recent study finds that most young breast cancer patients can conceive and give birth after treatment, especially after early fertility preservation.
May 24, 2024
New research by Dana-Farber Cancer Institute investigators has encouraging news for young women who have survived breast cancer and want to have children.
May 20, 2024
Study in women with high-risk genes and a pregnancy after breast cancer shows Assisted Reproductive Techniques are safe, with no increase in breast cancer recurrence.
May 1, 2024
After the issuance of updated recommendations for breast cancer screening by the U.S. Preventive Services Task Force (USPSTF) on April 29, a number of leading imaging specialists have offered their replies. Here, then, are summaries of statements issued in response. Imaging Technology News/ITN will continue to monitor and report on this important issue.
April 30, 2024
Women should start regular mammography screenings at age 40 and continue every other year until age 74, an expert advisory panel said Tuesday. Citing the increase in breast cancer among younger women, the U.S. Preventive Service Task Force (USPSTF) changed their previous guidance, which recommended biennial mammograms starting by age 50, but said the decision…
January 22, 2024
To understand how fertility concerns affect breast cancer treatment decisions, researchers analyzed data from the Young and Strong study.
January 5, 2024
An expert explained why chemotherapy-related amenorrhea in premenopausal women with breast cancer is “not just about having a period.”
December 28, 2023
Researchers at Dana-Farber Cancer Institute found that the diversity of T cells in peripheral blood declines with age in patients with breast cancer and, in younger patients, is lower in those diagnosed with metastatic disease than with ductal carcinoma in situ.
December 24, 2023
Researchers at Dana-Farber Cancer Institute have found that the diversity of T cells in peripheral blood declines with age in patients with breast cancer and, in younger patients, is lower in those diagnosed with metastatic disease than with ductal carcinoma in situ.